Exploring the role of germline genetic testing in surgical decision making for early-stage invasive breast cancer: insights from a safety-net hospital
Authors:
- Vineeth KommidiVKVineeth Kommidi
- Manasa KotamrajuMKManasa Kotamraju
- Keerthana ChakkaKCKeerthana Chakka
- Sharlene DongSDSharlene Dong
- Alexa BadalamentiABAlexa Badalamenti
- Caitlin Mauer HallCHCaitlin Mauer Hall
- Ashley QuinnAQAshley Quinn
- Emily GoffEGEmily Goff
- Chul AhnChul Ahn
- Ang GaoAGAng Gao
- Deborah FarrDFDeborah Farr
- Samira SyedSSSamira Syed
- 30 June 2025
- journal article
- research article
- Published by Springer Nature in Journal of Community Genetics
- Vol. 16 (6) , 737-746
Abstract
Current guidelines recommend contralateral prophylactic mastectomy (CPM) for women with unilateral breast cancer who have pathogenic/likely pathogenic variants (PV) in high-risk genes, but not for those with variants of uncertain significance (VUS). However, VUS results can cause significant psychosocial distress, which may influence surgical decision-making. In safety-net settings, concerns about insurance coverage and additional social determinants of health may further impact CPM decisions. This study examines surgical trends among patients with early-stage invasive breast cancer who underwent genetic testing before surgery at a safety-net hospital in Dallas, Texas between 2012–2022. We performed a retrospective chart review of 300 early-stage breast cancer patients referred for genetic counseling, analyzing demographics, tumor characteristics, genetic testing results, and treatment. Descriptive statistics and regression analyses were performed. The cohort included 116 patients without mutations (control), 111 with VUS, and 73 with PV. 86.30% of PV patients, 30.63% of VUS patients, and 18.10% of the control group underwent CPM. Multivariate analysis identified PV (OR 26.35, 95% CI: 10.97–63.29, p < 0.0001), VUS (OR 2.35, 95% CI: 1.16–4.77, p = 0.0175), and age at diagnosis (OR 0.963, 95% CI: 0.934–0.993, p = 0.0168) as independent predictors of CPM. These findings suggest that factors beyond established guidelines may influence surgical decision-making, particularly for patients in safety-net hospital settings, underscoring the need for thorough provider and patient counseling.Keywords
This publication has 32 references indexed in Scilit:
- Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic reviewJournal of Genetic Counseling, 2022
- Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivorsBreast Cancer Research and Treatment, 2022
- Clinical Utility of Universal Germline Genetic Testing for Patients With Breast CancerJAMA Network Open, 2022
- Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomyBreast Cancer Research and Treatment, 2022
- Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US MidwestJAMA Network Open, 2020
- Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patientsBreast Cancer Research and Treatment, 2020
- Heart Failure, Shared Decision-making, and Social Determinants of HealthJAMA Cardiology, 2019
- Psychological aspects, risk and protective factors related to BRCA genetic testing: a review of the literatureSupportive Care in Cancer, 2019
- Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancerCancer Medicine, 2018
- Impact of an embedded genetic counselor on breast cancer treatmentBreast Cancer Research and Treatment, 2018